Sygnature
Cambridge, MA, United States sygnaturediscovery.com From their website, Nov 2026
Work here? Claim this listing
About
Sygnature Discovery is a contract research organization that supports drug discovery and development programs from target identification through lead optimization, with scientific services spanning chemistry, bioscience, protein science, structural biology, DMPK, pharmacology, and formulation. It serves biotech and drug discovery clients through co-located teams and integrated programs, with sites in the United Kingdom and the United States.
Services
Integrated Drug Discovery
Delivers integrated drug discovery programs from target ID to candidate through co-located teams.
Target Identification & Validation
Combines AI, expert insights, and lab validation to evaluate targets and prepare them for hit discovery.
Hit Identification
Delivers validated, high-quality hits using integrated technologies and expert collaboration.
Hit-to-Lead
Profiles high-quality hits with early proof of concept to support lead optimization.
Lead Optimization
Works on promising leads to generate high-quality data and advance them toward clinical candidates.
Computer Aided Drug Design
Provides bioinformatics, target analysis, virtual screening, structure-based drug design, generative AI and machine learning, ligand-based drug design, library design, ADMET predictions, and informatics.
Protein Expression and Purification
Expresses and purifies proteins for downstream discovery and structural work.
Protein production
Membrane Protein Production and Characterization
Produces and characterizes membrane proteins.
Protein production
22 more services
- Antibodies and Biotherapeutics
- Structural Biology
- Cell Line Generation
- Assay Development
- Electrophysiology
- High Throughput Screening
- Cell Based Assays
- Biochemical Assays
- Biophysical Assays
- Physicochemical Profiling
- Non-Regulatory Toxicology Studies
- In Vivo Neurochemistry Services
- Targeted Protein Degradation
- Medicinal Chemistry
- Formulation
- Bioinformatics
- Virtual Screening
- Structure Based Drug Design
- Generative AI and Machine Learning
- Ligand Based Drug Design
- Library Design
- ADMET Predictions
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Antibody
- ADC
- Peptide
- Recombinant protein
- NMR
- Patch clamp
- HTS
- Data supplied
- NMR
Equipment
- X-ray crystallography
- Cryo-EM
- Macromolecular NMR
- Protein mass spectrometry
- FIDA
- Biacore™ SPR
- FIDA™
Materials
- Primary human cells
Industries served
- Biotech
- Drug discovery
Details
- Type
- CRO
- Founded
- 2011
- Based in
- Cambridge, MA, United States
- Sites
- Nottingham, United Kingdom
- Alderley Park, United Kingdom
- Serves
- EN, FR
Public records
- Parent company
- SYGNATURE LIMITED · GB GLEIF